Abstract
Diagnosis of invasive pulmonary aspergillosis (IPA) is often difficult. Recently, the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) has proposed new criteria for the classification of invasive fungal infections. We have studied the clinical applicability of this classification in 22 patients with hematological malignancies who had IPA at autopsy. While alive, according to the EORTC/MSG criteria, only 2 patients were classified as having proven IPA, 6 as probable, 13 as possible, and 1 was unclassifiable. Of the patients, 64% had no microbiological or major clinical criteria before death. Although the EORTC/MSG criteria are an important step forward in the standardization of definitions used for IPA in clinical research studies, most patients who die with extensive lung disease only reach a level of possible or probable IPA during life, further highlighting that these guidelines should not be used for clinical decision-making.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aisner J, Schimpff SC, Wiernik PH (1977) Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 86:359–543
Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14
Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L, Lopez J, Couillault G, Piard F, Vagner O, Guy H (2001) Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 19:253–259
Maertens J, Verhaegen J, Lagrou K, Van Elderle J, Boogaerts M (2001) Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97:1604–1610
Reichenberger F, Habicht J, Matt P, Frei R, Soler M, Bolliger CT, Dalquen P, Gratwohl A, Tamm M (1999) Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 24:1195–1199
Ulusakarya A, Chachaty E, Valenton J-M, Youssef A, Tancrède C, Pico JL, Bourhis JH, Fenaux P, Munck JN (2000) Surveillance of aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies. Hematol J 1:111–116
von Eiff M, Suhlsdorf M, Roos N, Hesse M, Schlten R, van de Loo J (1995) Pulmonary fungal infections in patients with hematological malignancies diagnostic approaches. Ann Hematol 70:135–141
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Subirà, M., Martino, R., Rovira, M. et al. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 82, 80–82 (2003). https://doi.org/10.1007/s00277-002-0599-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-002-0599-4